Back to Results
First PageMeta Content
Biology / Antibody-drug conjugate / Milatuzumab / Targeted therapy / Brentuximab vedotin / Yttrium (90Y) clivatuzumab tetraxetan / Hydrazone / Gemtuzumab ozogamicin / Monomethyl auristatin E / Monoclonal antibodies / Medicine / Pharmacology


Microsoft PowerPoint - World ADC San Francisco[removed]CLS
Add to Reading List

Document Date: 2013-10-18 09:49:14

Open Document

File Size: 1,27 MB

Share Result on Facebook

Company

Pfizer / IgG / ADC / Immunomedics / Seattle Genetics / Wyeth / ImmunoGen / Genentech / /

Country

United States / /

Currency

USD / /

Event

FDA Phase / Product Issues / Product Recall / /

Facility

ADC pipeline / pipeline ADCs / /

IndustryTerm

cancer therapy / cancer treatment / linker technologies / antibody coupling / chemical structure / alcohol chemical / /

MedicalCondition

tumor / Cancer / tumors / metastatic breast cancer / anaplastic large cell lymphoma / relapsed Hodgkin lymphoma / acute myeloid leukemia / /

MedicalTreatment

cancer therapy / /

Organization

FDA / Securities and Exchange Commission / /

Person

Cynthia L. Sullivan / /

Position

Private / President & CEO / /

Product

ADCs / Mylotarg / drug / SN-38 / polyethylene glycol / Kadcyla / /

Technology

linker technologies / treating cancer / /

SocialTag